triple negative breast cancer

Tumor-Targeted Magnetic Nanoparticles for Thermo-Controlled Drug Delivery

Janet Marielis Crespo Cajigas's picture

Triple Negative Breast Cancer or TNBC is a disease that affects 15% women all over the world. The current treatments for this and all cancers in general are chemotherapy and radiotherapy both of which are as harmful as they are helpful to the cells in the human body. However, the field of nanotechnology with applications in medicine is becoming a vital point in modern research. A regular cell is in the microscale in size which signifies that a nanoparticle (1,000 micrometers smaller) can easily find a way inside a cell and release the drug it carries.

Subscribe to RSS - triple negative breast cancer